We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$4.72B
AUM Growth
+$323M
Cap. Flow
+$92.3M
Cap. Flow %
1.96%
Top 10 Hldgs %
16.89%
Holding
1,475
New
127
Increased
594
Reduced
562
Closed
97

Sector Composition

Rank Sector Weight
1 Technology 17.88%
2 Financials 10.44%
3 Healthcare 10.37%
4 Industrials 8.75%
5 Consumer Discretionary 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BB icon
976
BlackBerry
BB
$5.05B
$453K 0.01%
+99,450
New +$394K
OUSA icon
977
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$747M
$453K 0.01%
10,748
-500
-4% -$20.8K
XENE icon
978
Xenon Pharmaceuticals
XENE
$6.11B
$451K 0.01%
+12,615
New +$466K
SLGN icon
979
Silgan Holdings
SLGN
$4.27B
$451K 0.01%
8,410
APPS icon
980
Digital Turbine
APPS
$984M
$451K 0.01%
36,511
-1,284
-3% -$17.3K
LSXMA
981
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$450K 0.01%
21,817
+1,211
+6% +$30.4K
PSLV icon
982
Sprott Physical Silver Trust
PSLV
$11.9B
$450K 0.01%
53,982
ISTB icon
983
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.11B
$449K 0.01%
9,522
-12,208
-56% -$571K
SKY icon
984
Champion Homes
SKY
$4.4B
$449K 0.01%
+5,965
New +$385K
TOTL icon
985
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.09B
$448K 0.01%
10,915
-90
-0.8% -$3.67K
K
986
DELISTED
Kellanova
K
$447K 0.01%
7,117
-1,010
-12% -$63.8K
HGLB
987
Highland Global Allocation Fund
HGLB
$175M
$447K 0.01%
49,500
+3,000
+6% +$29.1K
DBMF icon
988
iMGP DBi Managed Futures Strategy ETF
DBMF
$3.98B
$447K 0.01%
17,002
+6
+0% +$168
AWP
989
abrdn Global Premier Properties Fund
AWP
$372M
$447K 0.01%
36,165
+3,734
+12% +$46.9K
TAP icon
990
Molson Coors Class B
TAP
$7.76B
$445K 0.01%
8,619
-301
-3% -$15.6K
IYH icon
991
iShares US Healthcare ETF
IYH
$3.37B
$445K 0.01%
8,140
+255
+3% +$14K
PNW icon
992
Pinnacle West Capital
PNW
$12.2B
$443K 0.01%
5,586
-147
-3% -$11.1K
BBH icon
993
VanEck Biotech ETF
BBH
$399M
$440K 0.01%
2,715
+30
+1% +$4.85K
EFV icon
994
iShares MSCI EAFE Value ETF
EFV
$28.8B
$437K 0.01%
8,999
CROX icon
995
Crocs
CROX
$6.26B
$436K 0.01%
+3,451
New +$417K
BTI icon
996
British American Tobacco
BTI
$131B
$436K 0.01%
12,409
+214
+2% +$8.07K
CORT icon
997
Corcept Therapeutics
CORT
$12.3B
$433K 0.01%
20,000
IHF icon
998
iShares US Healthcare Providers ETF
IHF
$1.21B
$433K 0.01%
+8,750
New +$449K
EXG icon
999
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.99B
$431K 0.01%
55,189
-1,844
-3% -$14.3K
MTD icon
1000
Mettler-Toledo International
MTD
$28.4B
$430K 0.01%
281
+4
+1% +$6.01K

Similar funds

Oppenheimer & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Oppenheimer & Co held 1,475 positions worth $4.72B, up 7.3% from $4.39B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q1 2023 filing shows 127 new, 594 increased, 562 reduced and 97 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF December: 306,411 shares worth $9.8M. The largest sale was Oneok, an estimated $9.41M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q1 2023 buy was FT Vest US Equity Deep Buffer ETF December: 306,411 shares worth $9.8M.
  • Oppenheimer & Co added most to iShares Treasury Floating Rate Bond ETF in Q1 2023, an estimated $18.3M increase.
  • Oppenheimer & Co's biggest Q1 2023 reduction was Oneok, cutting an estimated $9.41M.
  • Oppenheimer & Co fully exited State Street SPDR Portfolio S&P 500 Value ETF in Q1 2023, selling an estimated $5.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.72B portfolio in Q1 2023.
  • Oppenheimer & Co opened 127 new positions and closed 97 in Q1 2023.
  • Oppenheimer & Co's portfolio value rose 7.3% quarter-over-quarter to $4.72B.

Based on Oppenheimer & Co's 13F filing for Q1 2023, filed 10 May 2023.